Tumour model

STO

SyngeneicIn vitro

Model characteristics

Organism
Mouse
Tissue of origin
Embryo
Pathology
Model type
In vitro, Syngeneic
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type

RD

Human
Embryo
Rhabdomyosarcoma
XenograftIn vitro
Mouse
Embryo
Teratocarcinoma
SyngeneicIn vitro
Mouse
Embryo
SyngeneicIn vitro
Mouse
Embryo
SyngeneicIn vitro
Mouse
Embryo
SyngeneicIn vitro
Mouse
Embryo
SyngeneicIn vitro